Security · CUSIP 55414P702
MABVAX THERAPEUTICS
EQUITIES · institutional ownership from 13F filings
13F holders
2
Shares held
35.3K
Value held
$15.0K
New / sold out
1 / 14
Added / reduced
0 / 0
net -1.3M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2018
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| PANAGORA ASSET MANAGEMENT INC | 26,382 | $11.0K | 0.00% |
| Biomark Capital Management Co. LLC | 8,903 | $4.0K | 0.04% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| PANAGORA ASSET MANAGEMENT INC | New | +26,382 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | Sold out | -1,030,310 | -100.0% |
| VANGUARD GROUP INC | Sold out | -126,592 | -100.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -75,904 | -100.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | Sold out | -27,865 | -100.0% |
| CITADEL ADVISORS LLC | Sold out | -27,385 | -100.0% |
| Virtu Financial LLC | Sold out | -12,783 | -100.0% |
| UBS Group AG | Sold out | -11,889 | -100.0% |
| BANK OF AMERICA CORP /DE/ | Sold out | -6,664 | -100.0% |
| ROYAL BANK OF CANADA | Sold out | -2,999 | -100.0% |
| CLS Investments, LLC | Sold out | -333 | -100.0% |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.